Literature DB >> 21740458

Intradermal capsaicin as a neuropathic pain model in patients with unilateral sciatica.

Verna Aykanat1, Melanie Gentgall, Nancy Briggs, Desmond Williams, Sharon Yap, Paul Rolan.   

Abstract

AIM: This study compared the responses between patients with unilateral sciatica and pain-free volunteers following administration of intradermal capsaicin. METHODS Fourteen patients with unilateral sciatica and 12 pain-free volunteers received one injection per hour over 4 h of 1 µg and 10 µg capsaicin, into each calf. For each dose, spontaneous pain (10 cm VAS), area of flare (cm²) and the sum of allodynia and hyperalgesia radii across eight axes (cm) were recorded pre-injection and at 5, 15, 30, 45 and 60 min post injection.
RESULTS: Sciatica subjects experienced higher spontaneous pain and hyperalgesia responses in both legs compared with pain-free volunteers. The largest mean difference in spontaneous pain was 2.8 cm (95% CI 1.6, 3.9) at 5 min in the unaffected leg following 10 µg. The largest mean difference in hyperalgesia was 19.7 cm (95% CI 12.4, 27.0) at 60 min in the unaffected leg following 10 µg. Allodynia was greater in patients than in controls with the largest mean difference of 2.9 cm (95% CI 1, 4.8) at 5 min following 10 µg in the affected leg. Allodynia was also higher in the affected leg compared with the unaffected leg in sciatica patients with the highest mean difference of 3.0 cm (95% CI 1.2, 4.7) at 5 min following 10 µg.
CONCLUSIONS: The responses to intradermal capsaicin are quantitatively and qualitatively different in unilateral sciatica patients compared with pain-free controls.
© 2011 The Authors. British Journal of Clinical Pharmacology © 2011 The British Pharmacological Society.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 21740458      PMCID: PMC3248254          DOI: 10.1111/j.1365-2125.2011.04059.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  38 in total

1.  Interpretation of visual analog scale ratings and change scores: a reanalysis of two clinical trials of postoperative pain.

Authors:  Mark P Jensen; Connie Chen; Andrew M Brugger
Journal:  J Pain       Date:  2003-09       Impact factor: 5.820

2.  The capsaicin receptor: a heat-activated ion channel in the pain pathway.

Authors:  M J Caterina; M A Schumacher; M Tominaga; T A Rosen; J D Levine; D Julius
Journal:  Nature       Date:  1997-10-23       Impact factor: 49.962

Review 3.  Windup and central sensitization are not equivalent.

Authors:  C J Woolf
Journal:  Pain       Date:  1996-08       Impact factor: 6.961

4.  Effects of intravenous ketamine, alfentanil, or placebo on pain, pinprick hyperalgesia, and allodynia produced by intradermal capsaicin in human subjects.

Authors:  Karen M Park; Mitchell B Max; Elaine Robinovitz; Richard H Gracely; Gary J Bennett
Journal:  Pain       Date:  1995-11       Impact factor: 6.961

5.  Spatial and temporal profiles of flare and hyperalgesia after intradermal capsaicin.

Authors:  H Sumikura; O K Andersen; A M Drewes; L Arendt-Nielsen
Journal:  Pain       Date:  2003-09       Impact factor: 6.961

6.  Secondary hyperalgesia to mechanical but not heat stimuli following a capsaicin injection in hairy skin.

Authors:  Z Ali; R A Meyer; J N Campbell
Journal:  Pain       Date:  1996-12       Impact factor: 6.961

7.  Assessment of the reproducibility of intradermal administration of capsaicin as a model for inducing human pain.

Authors:  Andrew Hughes; Angela Macleod; Jim Growcott; I Thomas
Journal:  Pain       Date:  2002-09       Impact factor: 6.961

8.  Capsaicin-evoked mechanical allodynia and hyperalgesia cross nerve territories. Evidence for a central mechanism.

Authors:  C N Sang; R H Gracely; M B Max; G J Bennett
Journal:  Anesthesiology       Date:  1996-09       Impact factor: 7.892

9.  Dynamic and static components of mechanical hyperalgesia in human hairy skin.

Authors:  Martin Koltzenburg; Lars E R Lundberg; Erik H Torebjörk
Journal:  Pain       Date:  1992-11       Impact factor: 6.961

Review 10.  [How neuropathic is sciatica? The mixed pain concept].

Authors:  R Baron; A Binder
Journal:  Orthopade       Date:  2004-05       Impact factor: 1.087

View more
  5 in total

Review 1.  Central N/OFQ-NOP Receptor System in Pain Modulation.

Authors:  Norikazu Kiguchi; Huiping Ding; Mei-Chuan Ko
Journal:  Adv Pharmacol       Date:  2015-12-17

2.  The effects of pregabalin and the glial attenuator minocycline on the response to intradermal capsaicin in patients with unilateral sciatica.

Authors:  Nicole M Sumracki; Mark R Hutchinson; Melanie Gentgall; Nancy Briggs; Desmond B Williams; Paul Rolan
Journal:  PLoS One       Date:  2012-06-07       Impact factor: 3.240

3.  A Randomized, Double-Blind, Placebo- and Active Comparator-Controlled Phase I Study of Analgesic/Antihyperalgesic Properties of ASP8477, a Fatty Acid Amide Hydrolase Inhibitor, in Healthy Female Subjects.

Authors:  Klaus Schaffler; Ashraf Yassen; Peter Reeh; Paul Passier
Journal:  Pain Med       Date:  2018-06-01       Impact factor: 3.750

4.  TRPV1-Like Immunoreactivity in the Human Locus K, a Distinct Subregion of the Cuneate Nucleus.

Authors:  Marina Del Fiacco; Maria Pina Serra; Marianna Boi; Laura Poddighe; Roberto Demontis; Antonio Carai; Marina Quartu
Journal:  Cells       Date:  2018-07-08       Impact factor: 6.600

5.  Potency and Stability of Intradermal Capsaicin: Implications for Use as a Human Model of Pain in Multicenter Clinical Trials.

Authors:  Pavan Balabathula; Himanshu Bhattacharjee; Laura A Thoma; Robert J Nolly; Frank P Horton; Gwendolyn D Stornes; Jim Y Wan; Ian M Brooks; Gloria A Bachmann; David C Foster; Candace S Brown
Journal:  Clin Exp Pharmacol       Date:  2014-01-01
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.